Literature DB >> 32332039

Renin-angiotensin-aldosterone system inhibitors and COVID-19.

Kieran L Quinn1, Michael Fralick2, Jonathan S Zipursky2, Nathan M Stall2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32332039      PMCID： PMC7241882          DOI： 10.1503/cmaj.200619

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19.

Authors:  Kieran L Quinn; Michael Fralick; Jonathan S Zipursky; Nathan M Stall
Journal:  CMAJ       Date:  2020-06-01       Impact factor: 8.262

Review 2.  Biologia Futura: is ADAM 17 the reason for COVID-19 susceptibility in hyperglycemic and diabetic patients?

Authors:  Ganna Stepanova
Journal:  Biol Futur       Date:  2021-06-08

3.  Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada.

Authors:  Michael A Campitelli; Susan E Bronskill; Laura C Maclagan; Daniel A Harris; Cecilia A Cotton; Mina Tadrous; Andrea Gruneir; David B Hogan; Colleen J Maxwell
Journal:  JAMA Netw Open       Date:  2021-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.